Holiday Closure:

ATTENTION: HealthWell Foundation headquarters and hotline will be closed on Thursday, November 26, 2020 and Friday, November 27, 2020 in observance of the holiday and will re-open on Monday, November 30, 2020 at 9:00 a.m. During this time, we encourage you to continue to use our Patient, Pharmacy and Provider Portals.  Please note: if you are contacting us about a payment or grant, it is faster to email us at  The HealthWell Team wishes you and yours a happy, safe and healthy holiday.

Dismiss alert


Treatments Covered

  • Acetadote
  • Acetylcysteine Novaplus
  • Adoxa
  • Alkeran
  • Avidoxy
  • Bortezomib
  • Cetylev
  • Cyclophosphamide
  • Decadron
  • Dexamethasone
  • Dexpak Taperpak
  • Dextenza
  • Dexycu
  • Doxycycline
  • Dxevo
  • Evomela
  • Gnc Nac 600
  • Hidex
  • Inotersen
  • Ixazomib
  • Mason Natural Nac
  • Maxidex
  • Melphalan
  • Monodox
  • N-acetylcysteine
  • Ninlaro
  • Okebo
  • Onpattro
  • Oracea
  • Ozurdex
  • Patisiran
  • Pomalidomide
  • Pomalyst
  • Rayos
  • Revlimid
  • Tafamidis
  • Taperdex
  • Targadox
  • Tegsedi
  • Velcade
  • Vibramycin Monohydrate
  • Vyndamax
  • Vyndaqel

Fund Definition

Co-payment or premium assistance for eligible beneficiaries to obtain prescription drug (or biologics) for the treatment of Amyloidosis.

Consider Premium Assistance

Under this fund, HealthWell can assist with premium costs. Medicare supplemental policies can help with cost shares related to many aspects of your health care. Using a HealthWell grant to cover premiums may be a better option than treatment-specific cost shares.

Do I Qualify?

HealthWell bases eligibility on an individual’s medical, financial and insurance situation. To qualify for HealthWell’s assistance, applicants must meet the following eligibility requirements:

  • 1.You are being treated for Amyloidosis.

    Please make sure that HealthWell currently has a fund for your diagnosis/indication and that your medication is covered under that fund by visiting our Disease Funds listing. If we do not have a fund that currently covers your diagnosis, please check back as we frequently open and reopen programs as funding becomes available. The Foundation is able to help patients receiving treatment for indications for which we currently have an open fund. We can only assist with medications that have been prescribed to treat the disease/covered diagnosis. You will be asked to provide the Foundation with the patient’s diagnosis, which must be verified by a physician, nurse practitioner, or physician assistant’s signature. The patient must receive treatment in the United States.

  • 2.You have insurance and it covers your medication.

    To qualify for assistance from HealthWell, you must have some form of health insurance (private insurance, Medicare, Medicaid, TriCare, etc.) that covers part of the cost of your treatment. The Foundation will refer patients without prescription insurance to other programs, such as manufacturer patient assistance programs.

  • 3.Your income falls within our guidelines.
    HealthWell assists individuals with incomes up to 400-500% of the Federal Poverty Level. The Foundation also considers the number in a household and cost of living in a particular city or state. If you believe you qualify for assistance, you may begin the application process here.
  • 4.You are receiving treatment in the United States.

    If you are receiving treatment in the U.S. and have met the eligibility criteria as listed, you are ready to apply! Please note that you will be asked to provide a Social Security Number in order to create a grant. This information is gathered to eliminate duplicate applications and is kept secure and confidential.

About Amyloidosis

Amyloidosis represents several different disease types where an abnormal protein called amyloid is produced. Amyloid protein fibers can attach and deposit into organs, tissues, nerves and other places in the body, affecting normal function of the area. As the protein increases, health problems and organ damage may occur, according to the Amyloidosis Foundation. Amyloidosis sometimes develops when a person has certain forms of cancer, such as multiple myeloma, Hodgkin’s disease or familial Mediterranean fever (an intestinal disorder). Systemic amyloidosis is slowly progressive and fatal if untreated.

Source: Amyloidosis Foundation

Close menu